ホライゾン・セラピューティクス社
US ˙ NASDAQ ˙ US44047T1097
このシンボルはもうアクティブではありません

SecurityHZNP / Horizon Therapeutics Plc
InstitutionKnott David M
Latest Disclosed Ownership20,000 shares
Latest Disclosed Value $ 2,191,000
Knott David M reports 37.50% decrease in ownership of HZNP / Horizon Therapeutics Plc

On November 12, 2021 - Knott David M filed a 13F-HR form disclosing ownership of 20,000 shares of Horizon Therapeutics Plc (US:HZNP) valued at $2,190,800 USD as of September 30, 2021. The entity filed a previous 13F-HR on August 13, 2021 disclosing 32,000 shares of Horizon Therapeutics Plc. This represents a change in shares of -37.50% during the quarter. The current value of the position is $2,326,000 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2021-11-12 2021-09-30 13F Horizon Therapeutics Public Common G46188101 20,000 -12,000 -37.50 2,191 -26.87 0.7961
2021-08-13 2021-06-30 13F Horizon Therapeutics Public Common G46188101 32,000 -8,614 -21.21 2,996 -19.85 1.0649
2021-05-13 2021-03-31 13F Horizon Therapeutics Public Common G46188101 40,614 -2,000 -4.69 3,738 19.92 1.5991
2021-02-12 2020-12-31 13F Horizon Therapeutics Public Common G46188101 42,614 5,083 13.54 3,117 6.93 1.4106
2020-11-13 2020-09-30 13F Horizon Therapeutics Public Common G46188101 37,531 1,000 2.74 2,915 43.60 1.7103
2020-08-12 2020-06-30 13F Horizon Therapeutics Public Common G46188101 36,531 -23,000 -38.64 2,030 15.14 1.1082
2020-05-13 2020-03-31 13F Horizon Therapeutics Public Common G46188101 59,531 -1,325 -2.18 1,763 -19.97 1.1126
2020-02-14 2019-12-31 13F Horizon Therapeutics Public Common G46188101 60,856 -3,508 -5.45 2,203 25.67 0.8930
2019-11-12 2019-09-30 13F Horizon Therapeutics Public Common G46188101 64,364 14,318 28.61 1,753 45.60 0.7365
2019-08-12 2019-06-30 13F Horizon Therapeutics Public Common G4617B105 50,046 2,206 4.61 1,204 -4.75 0.5079
2019-05-13 2019-03-31 13F Horizon Pharma Public Limited Common G4617B105 47,840 -25,800 -35.04 1,264 -12.16 0.5038
2019-02-12 2018-12-31 13F Horizon Pharma Public Limited Common G4617B105 73,640 0 0.00 1,439 -0.21 0.6762
2018-11-13 2018-09-30 13F Horizon Pharma Common G4617B105 73,640 0 0.00 1,442 18.29 0.4678
2018-08-13 2018-06-30 13F Horizon Pharma Common G4617B105 73,640 73,640 1,219 0.4570
2018-05-11 2018-03-31 13F Horizon Pharma Common G4617B105 0 -25,000 -100.00 0 -100.00
2018-02-13 2017-12-31 13F Horizon Pharma Common G4617B105 25,000 25,000 365 0.1452
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.